Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

ZYNE

Zynerba Pharmaceuticals (ZYNE)

Zynerba Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ZYNE
DateHeureSourceTitreSymboleSociété
09/02/202401h22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
19/10/202322h48Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
12/10/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202316h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202315h27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202315h27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314h56Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314h31Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314h00PR Newswire (US)HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINENASDAQ:ZYNEZynerba Pharmaceuticals Inc
04/10/202322h05GlobeNewswire Inc.Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and InstructionsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
29/09/202315h00GlobeNewswire Inc.Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023NASDAQ:ZYNEZynerba Pharmaceuticals Inc
27/09/202314h00PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/09/202322h15GlobeNewswire Inc.Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research SymposiumNASDAQ:ZYNEZynerba Pharmaceuticals Inc
05/09/202322h39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/08/202315h05Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/08/202314h23Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:ZYNEZynerba Pharmaceuticals Inc
24/08/202323h23Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/08/202322h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202323h29Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202323h20Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202313h36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202313h30PR Newswire (US)HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
08/08/202322h13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZYNEZynerba Pharmaceuticals Inc
08/08/202322h05GlobeNewswire Inc.Zynerba Pharmaceuticals Announces New Date for Reconvened Annual MeetingNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/06/202322h21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/06/202322h05GlobeNewswire Inc.Zynerba Pharmaceuticals Announces Further Adjournment of Annual MeetingNASDAQ:ZYNEZynerba Pharmaceuticals Inc
21/06/202322h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
20/06/202313h00GlobeNewswire Inc.Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual ConferenceNASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/06/202322h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ZYNE